[1] LI T, APTE U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer[J]. Adv Pharmacol, 2015, 74(4):263-302.
[2] LI T, CHIANG J Y. Bile acid signaling in metabolic disease and drug therapy[J]. Pharmacol Rev, 2014, 66(4):948-983.
[3] MALESZKA A, DUMNICKA P, MATUSZYK A, et al. The diagnostic usefulness of serum total bile acid concentrations in theearly phase of acute pancreatitis of varied etiologies[J]. Int J Mol Sci,2017, 18(1):106-116.
[4] WU Z, LU Y, WANG B, et al. Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines[J]. World J Gastroenterol, 2003, 9(12):2759-2763.
[5] MARTIN F J, MONTOLIU I, KUSSMANN M. Metabonomics of ageing-Towards understanding metabolism of a long and healthy life[J]. Mech Ageing Dev,2017,165(PtB):171-179.
[6] QI Y, JIANG C, CHENG J, et al. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice[J]. Biochim Biophys Acta,2015, 1851(1):19-29.
[7] LAVOIE J M. Dynamics of hepatic and intestinal cholesterol and bile acid pathways: the impact of the animal model of estrogen deficiency and exercise training[J]. World J Hepatol,2016, 8(23):961-975.
[8] XIANG D, ZHANG C L, YU Z Q, et al. Research progress of bile acid transporters[J]. Chin Pharm J(中国药学杂志), 2017, 52(3):567-573.
[9] GRIFFITHS W J, SJOVALL J. Bile acids: analysis in biological fluids and tissues[J]. J Lipid Res, 2010, 51(1):23-41.
[10] DOLOWY M. Application of selected topological indices to predict retention parameters of selected bile acids separated on modified TLC plates[J]. Acta Pol Pharm,2008, 65(1):51-57.
[11] ONISOR C, POSA M, KEVRESAN S, et al. Estimation of chromatographic lipophilicity of bile acids and their derivatives by reversed-phase thin layer chromatography[J]. J Sep Sci, 2010, 33(20):3110-3118.
[12] SARBU C, KUHAJDA K, KEVRESAN S. Evaluation of the lipophilicity of bile acids and their derivatives by thin-layer chromatography and principal component analysis [J]. J Chromatogr A,2001, 917(1-2):361-366.
[13] SHI Y, XIONG J, SUN D, et al. Simultaneous quantification of the major bile acids in artificial calculus bovis by high-performance liquid chromatography with precolumn derivatization and its application in quality control[J]. J Sep Sci,2015, 38(16):2753-2762.
[14] KAKIYAMA G, MUTO A, TAKEI H, et al. A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS[J]. J Lipid Res, 2014, 55(5):978-990.
[15] MARTINEFSKI M, CONTIN M, SAMASSA P, et al. The importance of analytical methodology in accurate diagnosis and monitoring of intrahepatic cholestasis of pregnancy[J]. Int J Gynaecol Obstet, 2013, 123(1):78-79.
[16] HOLM R, SCHONBECK C, ASKJAER S, et al. Complexation of tauro-and glyco-conjugated bile salts with alpha-cyclodextrin and hydroxypropyl-alpha-cyclodextrin studied by affinity capillary electrophoresis and molecular modelling[J]. J Sep Sci,2011, 34(22):3221-3230.
[17] TSAI S J, ZHONG Y S, WENG J F, et al. Determination of bile acids in pig liver, pig kidney and bovine liver by gas chromatography-chemical ionization tandem mass spectrometry with total ion chromatograms and extraction ion chromatograms[J]. J Chromatogr A, 2011, 1218(3):524-533.
[18] KUMAR B S, CHUNG B C, LEE Y J, et al. Gas chromatography-mass spectrometry-based simultaneous quantitative analytical method for urinary oxysterols and bile acids in rats[J]. Anal Biochem,2011, 408(2):242-252.
[19] YERIGUI, WU X H, WANG X J, et al. Quantification of bile acids in traditional animal medicines and their preparations using ultra high-performance liquid chromatography-mass spectrometry in the multiple reaction monitoring mode[J]. Anal Sci,2016, 32(5):499-503.
[20] JOHN C, WERNER P, WORTHMANN A, et al. A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids[J]. J Chromatogr A, 2014, 1371(5):184-195.
[21] HAN J, LIU Y, WANG R, et al. Metabolic profiling of bile acids in human and mouse blood by LC-MS/MS in combination with phospholipid-depletion solid-phase extraction[J]. Anal Chem,2015, 87(2):1127-1136.
[22] ZHOU X, CAO L, JIANG C, et al. PPARalpha-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis[J]. Nat Commun, 2014, 5(1):4573-4588.
[23] BATHENA S P, MUKHERJEE S, OLIVERA M, et al. The profile of bile acids and their sulfate metabolites in human urine and serum[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2013, 942-943(24):53-62.
[24] AMPLATZ B, ZOHRER E, HAAS C, et al. Bile acid preparation and comprehensive analysis by high performance liquid chromatography-high-resolution mass spectrometry[J]. Clin Chim Acta, 2017, 464(1):85-92.
[25] TANG X, YANG Q, YANG F, et al. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice[J]. J Ethnopharmacol, 2016, 194: 63-71.
[26] ARAB J P, KARPEN S J, DAWSON P A, et al. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives[J]. Hepatology, 2017, 65(1):350-362.
[27] SUGITA T, AMANO K, NAKANO M, et al. Analysis of the serum bile acid composition for differential diagnosis in patients with liver disease[J]. Gastroenterol Res Pract, 2015, 2015: 717431. doi:10.1155/2015/717431.
[28] LV L, ZHAO L, LAN H T, et al. Determination of 13 kinds of bile acid in healthy people and patients with primaryliver cancer by HPLC-MS [J]. J Pharm Pract(药学实践杂志), 2014, 32(4):270-272.
[29] YANG T. Application of metabolic profiling analysis of urinary bile acids in diagnosis and grading of intrahepatic cholestasis of pregnancy [D]. Chongqing:Chongqing Medical University(重庆医科大学), 2015.
[30] TIAN G, ZHEN Q N, BAN Y N, et al. Intrahepatic cholestasis of pregnancy diagnosis based on metabolic profilingof serum bile acid[J]. J Chongqing Med Univ (重庆医科大学学报), 2011, 36(5):586-588.
[31] YANG F, TANG X, DING L, et al. Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation[J]. Sci Rep,2016, 6: 33052. doi:10.1038/srep33052.
[32] SHI Y, WEI Y, ZHANG T, et al. Deoxycholic acid could induce apoptosis and trigger gastric carcinogenesis on gastric epithelial cells by quantitative proteomic analysis[J]. Gastroenterol Res Pract, 2016, 2016(3):1-10.
[33] KULIGOWSKI J, SANJUAN-HERRAEZ D, VAZQUEZ-SANCHEZ M A, et al. Metabolomic analysis of gastric cancer progression within the correa′s cascade using ultraperformance liquid chromatography-mass spectrometry[J]. J Proteome Res,2016, 15(8):2729-2738.
[34] LIANG Q, WANG C, LI B. Metabolomic analysis using liquid chromatography/mass spectrometry for gastric cancer[J]. Appl Biochem Biotechnol, 2015, 176(8):2170-2184.
[35] CASTRO P G, LOPEZ S A, CARRACEDO I R, et al. Cancer of the operated stomach: a descriptive study on the experience of the last 12 years[J]. Rev Clin Esp,1999, 199(5):264-269.
[36] JOHNSON J S, OPIYO M N, THOMSON M, et al. 11beta-hydroxysteroid dehydrogenase-1 deficiency alters the gut microbiome response to Western diet[J]. J Endocrinol,2017, 232(2):273-283.
[37] HU X, BONDE Y, EGGERTSEN G, et al. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism[J]. J Intern Med, 2014, 275(1):27-38.
[38] DEVKOTA S, WANG Y, MUSCH M W, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice[J]. Nature, 2012, 487(7405):104-108.
[39] WATANABE M, HOUTEN S M, MATAKI C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation[J]. Nature, 2006, 439(7075):484-489.
[40] HUANG F J. Study on detection method of bile acids spectrum in complex biological samples and chemical constituents from thunbergia [D]. Shanghai:Shanghai Jiaotong University, 2013.
[41] ZHANG J, XU J J, FANG L, et al. Determination of nine bile acids in micro-amount of serum by ultra-high performance liquid chromatography tandem mass spectrometry and its clinical significance[J]. J Intern Med Concepts Pract(内科理论与实践), 2015, 10(3):205-209.
[42] FANG S, SUH J M, REILLY S M, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance[J]. Nat Med, 2015, 21(2):159-165.
[43] MANO N, GOTO T, UCHIDA M, et al. Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain[J]. J Lipid Res,2004, 45(2):295-300.
[44] JANSEN P L, GHALLAB A, VARTAK N, et al. The ascending pathophysiology of cholestatic liver disease[J]. Hepatology,2016, 65(2):722-738.
[45] QUINN M, MCMILLIN M, GALINDO C, et al. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms[J]. Dig Liver Dis,2014, 46(6):527-534.
[46] CASH W J, MCCONVILLE P, MCDERMOTT E, et al. Current concepts in the assessment and treatment of hepatic encephalopathy[J]. Qjm Monthly J Assoc Physicians,2010, 103(1):9-16.
[47] TRIPODI V, CONTIN M, FERNANDEZ M A, et al. Bile acids content in brain of common duct ligated rats[J]. Ann Hepatol,2012, 11(6):930-934.
[48] LORINCZ M T, RAINIER S, THOMAS D, et al. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized[J]. Arch Neurol,2005, 62(9):1459-1463.
[49] NIE S, CHEN G, CAO X, et al. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management[J]. Orphanet J Rare Dis,2014, 9(1):179-189.
[50] JOYCE S A, GAHAN C G. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health[J]. Annu Rev Food Sci Technol, 2016, 7(1):313-333.